Skip to main content
FinSpry Logo
FinSpry
MGNX logo
MGNX
(NASDAQ)
MacroGenics, Inc.
$4.01-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

MacroGenics (MGNX) Stock Price & Financial Analysis

MacroGenics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.00 - $4.29
52-Week High$5.08
52-Week Low$1.29
Open$4.21
Volume569.64K
Average Volume (3M)1.15M
Market Cap272.83M
Shares Outstanding63.45M
Price to Sales (P/S)1.66
Price to Book (P/B)12.33
EV/EBITDA-4.57
Revenue (TTM)157.08M
Net Income (TTM)-70.36M
Free Cash Flow (TTM)-71.69M
EPS (TTM)$-1.11
Profit Margin-44.79%
Operating Margin-40.53%
Return on Equity (ROE)-331.91%
Debt to Equity1.72
50-Day MA$4.20
200-Day MA$2.60
52-Week Change167.53%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About MacroGenics

What is the current stock price for MGNX?

As of the latest trading session, MGNX stock trades at $4.01. The 52-week range is $1.29–$5.08, with a day range of $4.00–$4.29.

What is the P/E ratio for MGNX?

The P/E ratio (Price-to-Earnings) for MGNX is shown in the Key Statistics section. This valuation metric helps compare MacroGenics, Inc. to industry peers.

Does MGNX pay dividends?

MacroGenics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MGNX?

Based on 4 analysts, the consensus for MGNX is Buy.

What is the market cap of MGNX?

MacroGenics's market capitalization is $254.4M, classifying it as a micro-cap company. MacroGenics operates in the Healthcare sector within the Biotechnology industry.